DARA BioSciences, Inc. (DARA)

[macjockey]

Would love to see the video when you have time. I have raised significant capital for companies with a much smaller window for success then Dara. I just attended an investment meeting held at Microsoft in Santa Clara a few weeks ago, and their were several Bio companies pitching that had nothing like the portfolio and positioning that Dara has. Raising operating capital while ramping marketing and sales support is pretty standard. When you look at the background experience of the Dara executive team, this isn't their first rodeo, and with the Alamo partnership the channel of opportunity just diversifies. This company will likely be quite valuable between Q4 2014 and end of Q1 2015. KRN will be the wild card. If FDA gives them clinical access anytime soon, value increases exponentially. With Alamo's access, pitching a non opioid CCIPN pain management drug is like selling ice water in Palm Springs.